Medications for Pulmonary Embolism

4 results
  • eliquis - apixaban tablet, film coated

    (Apixaban)
    E.R. Squibb & Sons, L.L.C.
    Eliquis is a factor Xa inhibitor used in adults to reduce stroke risk in nonvalvular atrial fibrillation, prevent DVT after hip/knee surgery, and treat/prevent recurrent DVT and PE. Also indicated for VTE treatment and recurrence reduction in pediatric patients after initial anticoagulation.
  • pradaxa - dabigatran etexilate mesylate capsule

    (Dabigatran Etexilate Mesylate)
    Boehringer Ingelheim Pharmaceuticals Inc.
    Pradaxa is a direct thrombin inhibitor used to reduce stroke and embolism risk in adults with non-valvular atrial fibrillation, treat and prevent recurrence of DVT and pulmonary embolism in adults, prevent DVT/PE after hip replacement, and treat or prevent VTE recurrence in patients aged 8–17.
  • savaysa - edoxaban tosylate tablet, film coated

    (Edoxaban Tosylate)
    Daiichi Sankyo Inc.
    SAVAYSA is a factor Xa inhibitor that reduces stroke and systemic embolism risk in nonvalvular atrial fibrillation, and treats deep vein thrombosis and pulmonary embolism after initial parenteral anticoagulation. Not for patients with creatinine clearance above 95 mL/min.
  • xarelto - rivaroxaban tablet, film coated

    (Rivaroxaban)
    Janssen Pharmaceuticals, Inc.
    Xarelto is a factor Xa inhibitor that reduces stroke risk in atrial fibrillation, treats and prevents DVT and pulmonary embolism, lowers cardiovascular risk in CAD and PAD (with aspirin), and provides VTE prophylaxis after joint replacement surgery, in hospitalized medical patients, and in pediatric patients.